StockVaultSandbox
ScreenerSectorsLearnMethodDesign
Request access
StockVaultSandbox
ScreenerSectorsLearnMethodDesign
Request access
Back to screenerCompare

KIMS — KRISHNA INST OF MED SCI L

Structural concernsWeak profitability

Price History

Data as of 26 Jun 2026· via fincrux

How KIMS has traded over time.

Is the price reasonable right now?

Where today's price sits within its own 12-month range — context, not advice.

Upper end of its 12-month range95% of range

Trading about 37% above its 12-month low and near recent highs — historically pricier territory for this stock. It sits above its 200-day average, the longer-term trend.

₹582 low₹807 high
vs 50-day avg
+7.1%
vs 200-day avg
+14.8%
Beginner mode
Plain English, with everything explained

KIMS

NSE

KRISHNA INST OF MED SCI L

Healthcare / Hospitals

₹795.35
0.00%
last close
0%
Quality Score
Several red flagsBig money steady

KRISHNA INST OF MED SCI L clears only 1 of 3 checks. The numbers flag real concerns — exactly the kind of thing that gets lost in exciting news or social-media buzz. Tread carefully.

Company size
₹30365.00 Cr
Price tag
114.0×
Money it earns
11.6%

The four quality checks

Every company faces the same four checks. Tap the ? on any term to learn what it means.

01

Is the company drowning in loans?

We check how much the company has borrowed versus its own money. Too much debt makes a business fragile when times get tough.

Watch

Borrowing is a little on the higher side. Worth keeping an eye on.

D/E 0.63goal < 0.5
02

Does it make good money, consistently?

We look at how much profit the company squeezes out of its owners' money, averaged over three years — not just one lucky quarter.

Divergent

Profits relative to the money invested are on the weaker side over the last few years.

ROE 11.6%goal > 15% (3y avg)
03

Is the big, smart money buying in?

Large professional investors (global funds and Indian mutual funds) do deep research before buying. We track whether they've been adding or trimming their stake.

Aligned

Professional investors have been holding steady or buying more — a quiet vote of confidence.

FII+DII 47.1%goal stable or rising (2Q)
04

Is the price reasonable right now?

Even a great company can be a bad buy if it's overpriced. We compare today's price tag to how this company has typically been priced over the past five years.

No data

We don't have enough reliable data to run this check yet, so we're leaving it open rather than guessing.

Data unavailablegoal P/E < 5y median

What we noticed

Observations from the data — not recommendations.

  • Krishna Medical Institution Ltd (KIMS) was Incorporated in the year 1973 and is one of the largest corporate healthcare groups in Andhra Pradesh and Telangana in terms of patients treated and treatments offered. The com…
Data as of 26 Jun 2026· via fincrux

StockVault is an educational research and mathematical-modeling sandbox. It presents structural readings derived from public data and does not provide investment advice, recommendations, or target prices. Figures shown are illustrative and delayed. Markets carry risk; decisions are your own.

Balance Sheet

What KIMS owns and owes over the years. Tap the ? on any line to learn what it means.

Line itemFigures in ₹ crore
ItemMar '22Mar '23Mar '24Mar '25Mar '26
Borrowings1843267081,526
Equity Capital8080808080
Reserves1,2981,5511,7862,0882,349
Total Assets1,5691,8122,3973,1894,285
Total Liabilities1,5691,8122,3973,1894,285

Borrowings rising

Total borrowings are up about 8378% over the last 5 years — worth watching alongside how much it earns.

Periodic Performance

Yearly net profit for KIMS — does it earn money consistently?

Potential turnaroundPotential turnaround (pattern in the data)

Profit dipped in the middle years and has been recovering in the most recent ones. That's a pattern in the data, not a forecast.

₹278 Cr
₹252 Cr
₹235 Cr
₹303 Cr
₹261 Cr
Mar '22Mar '23Mar '24Mar '25Mar '26
rev ₹1,143 Crrev ₹1,132 Crrev ₹1,222 Crrev ₹1,384 Crrev ₹1,702 Cr
Net profit · annualProfitLoss

Strengths & Risks

What the numbers say is good and bad about KIMS — observations, not recommendations.

Strengths

2
  • Large professional investors have been holding steady or adding to their stake.
  • Recent results show a return to profit after weaker years — a turnaround pattern in the data.

Risks

2
  • Profit generated from the money invested has been on the weaker side.
  • Sits near the top of its 12-month range — historically pricier territory for this stock.

Institutional Ownership Trend

FII and DII holding across the last four quarters.

FII· Foreign institutions
14.6%-1.0 pp
DII· Domestic institutions
32.5%+0.9 pp
Jun '25Sep '25Dec '25Mar '26

Sector Peers

How others in Healthcare / Hospitals score on the same four guardrails.

  • APOLLOHOSPAPOLLO HOSPITALS ENTER. L100
  • NHNARAYANA HRUDAYALAYA LTD.69
  • FORTISFORTIS HEALTHCARE LTD63
  • ASTERDMASTER DM HEALTHCARE LTD.63
  • MAXHEALTHMAX HEALTHCARE INS LTD47
View the full sector